Outcomes, quality of life, and survival after esophagectomy for squamous cell carcinoma: A propensity score-matched comparison of operative approaches.

Hao Wang,Yaxing Shen,Mingxiang Feng,Yi Zhang,Wei Jiang,Songtao Xu,Lijie Tan,Qun Wang
DOI: https://doi.org/10.1016/j.jtcvs.2014.12.063
2015-01-01
Abstract:Background: Minimally invasive esophagectomy (MIE) theoretically offers advantages compared with open esophagectomy (OE). However, the long-term outcomes have not been well studied, especially for esophageal squamous cell carcinoma. We retrospectively compared postoperative outcomes, quality of life (QOL), and survival in a matched population of patients undergoing MIE, with a control (OE) group. Methods: From May 2004 to August 2013, MIE was performed for a group of 735 patients, which was compared with a group of 652 cases of OE. Eventually, 444 paired cases, matched using propensity-score matching, were selected for further statistical analysis. Results: Compared with the OE group, the MIE group had shorter operation duration (191 +/- 47 minutes vs 211 +/- 44 minutes, P < .001); less blood loss (135 +/- 74 ml vs 163 +/- 84 ml, P < .001); similar lymph node harvest (24.1 +/- 6.2 vs 24.3 +/- 6.0, P = .607); shorter postoperative hospital stay (11 days [range: 7-90 days] vs 12 days [range: 8-112 days], P < .001); fewer major complications (30.4% vs 36.9%, P = .039); a lower readmission rate to the intensive-care unit (5.6% vs 9.7%, P = .023); and similar perioperative mortality (1.1% vs 2.0%, P = .281). At a median follow-up of 27 months, the 2-year overall survival rates in the MIE and OE group were: (1) stage 0 and I: 92% versus 90% (P = .864); (2) stage II: 83% versus 82% (P = .725); (3) stage III: 59% versus 55%(P = .592); (4) stage IV: 43% versus 43%(P = .802). The generalized estimating equation analysis showed that MIE had an independently positive impact on patients' postoperative QOL. Conclusions: In our experience, MIE is a safe and effective procedure for the treatment of esophageal squamous cell carcinoma. It may offer better perioperative outcomes, better postoperative QOL, and equal oncologic survival, compared with OE.
What problem does this paper attempt to address?